Market access and HTA – a snapshot of recent developments with Sreeram Ramagopalan: December 2023–February 2024

Written by Sreeram Ramagopalan (Lane Clark & Peacock)
Guest columns Health technology assessment Industry Updates Interviews Journal articles Market access Regulation Value assessment
Market access and HTA highlights from Sreeram Ramagopalan header image

Read the latest installment of Sreeram Ramagopalan’s (Lane Clark & Peacock, UK) market access and HTA highlights, a snapshot from his Industry Update article published bi-monthly in our partner journal, the Journal of Comparative Effectiveness Research. Read the full update in the Journal of Comparative Effectiveness Research here >>> What happened over these months that you were expecting? The concern from Sweden’s TLV ((Tandvårds-och läkemedelsförmånsverke) around the EU HTA was not unexpected. According to TLV's 2023 annual report, the agency noted several challenges in preparing for EU HTA: Producing PICOs (Population, Intervention, Comparison, Outcome) for all products processed by the EMA,...

To view this content, please register now for access

It's completely free